Grace Therapeutics (GRCE)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	15.16 mm	15.16 mm	15.16 mm	15.16 mm	15.16 mm	15.16 mm
Cash burn (monthly)	1.41 mm	986.33 k	1.61 mm	1.41 mm	1.41 mm	984.58 k
Cash used (since last report)	6.04 mm	4.22 mm	6.89 mm	6.02 mm	6.04 mm	4.21 mm
Cash remaining	9.11 mm	10.94 mm	8.27 mm	9.14 mm	9.11 mm	10.95 mm
Runway (months of cash)	6.4	11.1	5.1	6.5	6.4	11.1

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

GRCE institutional ownership history Ownership history

26.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	13	11	+18.2%
Opened positions	3	11	-72.7%
Closed positions	1	0	NEW
Increased positions	4	0	NEW
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	6.30 bn	4.34 bn	+45.3%
Total shares	2.72 mm	1.83 mm	+48.4%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
ADAR1 Capital Management	959.57 k	$2.80 bn	+341.4%
AIGH Capital Management	641.08 k	$1.88 bn	+28.9%
Hirschman Orin	567.81 k	$1.93 mm	0.0%
BAC Bank of America	494.70 k	$1.44 bn	0.0%
Susquehanna International	37.79 k	$113.00 mm	+3.1%
UBS UBS	7.74 k	$22.59 mm	+297.3%
RY Royal Bank of Canada	6.58 k	$20.00 mm	-47.7%
NA.R National Bank of Canada	2.90 k	$8.29 mm	0.0%
MS Morgan Stanley	1.88 k	$5.50 mm	0.0%
Activest Wealth Management	104.00	$304.00 k	NEW

Largest transactions	Shares	Bought/sold	Change
ADAR1 Capital Management	959.57 k	+742.19 k	+341.4%
AIGH Capital Management	641.08 k	+143.72 k	+28.9%
RY Royal Bank of Canada	6.58 k	-6.00 k	-47.7%
UBS UBS	7.74 k	+5.79 k	+297.3%
Susquehanna International	37.79 k	+1.14 k	+3.1%
Activest Wealth Management	104.00	+104.00	NEW
IFP Advisors	6.00	+6.00	NEW
JPM JPMorgan Chase & Co.	2.00	+2.00	NEW
NBC Securities	0.00	-2.00	EXIT
BAC Bank of America	494.70 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

GRCE insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
6 May 24	Prashant Kohli	Stock Options Class A Common Shares	Grant	Acquire A	No	No	2.96	128,770	381.16 k	128,770
6 May 24	Amresh Kumar	Stock Options Class A Common Shares	Grant	Acquire A	No	No	2.96	19,740	58.43 k	19,740
6 May 24	R. Loch Macdonald	Stock Options Class A Common Shares	Grant	Acquire A	No	No	2.96	25,380	75.12 k	25,380

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Grace Therapeutics Q2 2025 GAAP EPS $(0.30) Beats $(0.44) Estimate

13 Nov 24

Grace Therapeutics (NASDAQ:GRCE) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.44) by 31.82 percent.